John Wiley and Sons Ltd, New York, United States
John Wiley & Sons Inc
12th Aug 1991
w 154mm h 235mm
This work concentrates on fragile X syndrome and cancer genetics, examining the parallel development and application of both molecular and cytogenetic technologies for the diagnosis and treatment of these genetic disorders.
Cookies are disabled, please note some site features may not function correctly.
We allow third parties to store cookies in order to better understand traffic patterns and user habits,